Hangzhou Grascent Co., Ltd.

Hangzhou Grascent Co., Ltd.

301688.SZ
Hangzhou Grascent Co., Ltd.CN flagShenzhen Stock Exchange
39.16
CNY
+1.05
- -
5.22BMarket Cap
Hangzhou Grascent Co., Ltd.
301688.SZ
(Shenzhen Stock Exchange)

Recent

price

39.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8.26
10.11
9.97
9.56
10.5
6.3
7.35
9.58
10.75
- -
Revenue per Share
0.6
0.82
1.26
1.14
0.72
0.68
0.93
1.5
1.79
- -
Basic EPS, GAAP
0.54
0.5
1.25
1.18
-2.57
-1.34
-1.04
0.08
0.7
- -
Free Cash Flow per Basic Share
0.26
1.26
0.77
0.2
0.37
1
0.28
1.09
0.27
- -
Dividend per Share
1.75
2.08
2.41
2.89
3.13
3.04
3.71
4.25
5.62
4.02
Book Value per Share
1.29
1.63
1.93
2.4
2.62
2.39
3.07
3.58
4.98
4.02
Tangible Book Value per Share
51
51
57
57
57
100
100
100
100
- -
Basic Weighted Avg Shares
421
515
567
540
594
631
735
961
1,075
815
Sales/Revenue/Turnover
13.03
13.65
16.7
16.65
10.59
14.97
16.8
20.16
22.16
25.01
Operating Margin (%)
26
27
28
29
32
38
41
60
75
- -
Depreciation Expense
31
42
72
64
41
68
93
150
179
115
Net Income, GAAP
15.68
12.09
12.55
9.16
9.12
9.03
11.6
13.1
13.25
- -
Effective Tax Rate (%)
7.27
8.11
12.64
11.93
6.85
10.79
12.65
15.66
16.65
14.14
Profit Margin (%)
-106
-70
-52
84
128
37
-8
45
166
- -
Working Capital
25
25
- -
111
227
376
474
565
481
- -
LT Debt
233
278
322
385
418
405
495
566
749
536
Total Equity
- -
12.09
14.85
13.96
8.34
9.81
9.98
12.87
13.85
118.3
Return on Invested Capital (%)
- -
11.04
14.99
14.38
10.37
14.63
14.08
16.31
15.03
75.06
Return on Capital (%)
- -
16.38
23.91
18.22
10.15
16.56
20.65
28.36
27.22
100.08
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
ST Debt
- -
254
- -
LT Borrowings
- -
474
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
133
133
133
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
Total Current Assets
- -
452
- -
Cash, Cash Equivalents & STI
- -
24
- -
Accounts Receivable, Net
- -
143
- -
Inventories
- -
222
- -
Total Current Liabilities
- -
460
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
254
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
14.85%
32.26%
Free Cash Flow
- -
57.53%
742.5%
Net Income, GAAP
- -
29.54%
18.95%
Sales/Revenue/Turnover
- -
15.06%
11.9%
Total Cash Common Dividend
- -
120.21%
-75.14%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
238
- -
- -
- -
961
2025
274
273
- -
- -
1,075
2026
318
290
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.5
2025
- -
- -
- -
- -
1.79
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.09
2025
- -
- -
- -
- -
0.27
2026
- -
- -
- -
- -
- -
Business
Hangzhou Grascent Co., Ltd. engages in the research, development, production and sale of bio-based and fully synthetic fragrance and flavor ingredients, including cedarwood oil derivatives, turpentine oil derivatives and synthetic aroma chemical series; its portfolio is used in daily chemicals, cosmetics, fine fragrance and related applications. Founded in 1999 and headquartered in Jiande, Zhejiang Province, China, the company operates modern production bases in Jiande and Nanping and serves domestic and international customers through a structured industrial system with annual capacity exceeding 12,000 tons. Hangzhou Grascent also manufactures and supplies cypress oil series products, turpentine oil series products and fully synthetic fragrance materials, and it positions itself as the global primary registrant for five core REACH-regulated products, including methyl cedryl ketone. In recent developments, the company completed its listing on the ChiNext Board of the Shenzhen Stock Exchange on September 2, 2026 under ticker 301688.SZ, following an initial public offering that raised nearly 878 million yuan and involved the issuance of 33.33 million shares. The IPO and listing mark a significant strategic milestone and support the company’s continued expansion in aroma chemicals and fragrance ingredients, while reinforcing its role as a specialty chemicals supplier focused on fragrance and flavor applications.